相关实验视频

Updated: Sep 11, 2025

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.3K

使用乙烯乙烯醇 (EVOH) 聚合物进行前列腺动脉栓塞治疗良性前列腺增生:十二个月分析

Jacques Sédat1, Eric Fontas2, Paolo Arnoffi3

  • 1Service d'Interventionnel Neurologique et Général, CHU de Nice, Hôpital Pasteur 2, 30 Voie Romaine, Nice, France. jsedat@yahoo.fr.

Cardiovascular and interventional radiology
|August 13, 2025
PubMed
概括

使用乙烯乙烯酒合聚合物进行前列腺动脉栓塞是良性前列腺增生的一个安全程序. 虽然它改善了尿路症状,但它并没有显著减少前列腺体积或12个月后空虚的残留体积.

关键词:
良性前列腺增生症是什么乙烯乙烯醇共聚合物 乙烯乙醇共聚物下泌尿道的症状 下泌尿道的症状前列腺动脉栓塞发生前列腺动脉栓塞.

更多相关视频

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.1K
Vessel-sparing Excision and Primary Anastomosis08:09

Vessel-sparing Excision and Primary Anastomosis

Published on: January 7, 2019

11.6K

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
254
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
225